Emily Gosselin
Senior Scientist Corner Therapeutics
Seminars
Wednesday 3rd June 2026
A T-Cell Selective LNP to Deliver STING Agonists to Eliminate Autoimmune T-Cells
4:30 pm
- RNA-based therapy that controls the cGAS-STING pathway in vivo
- cGAS-STING pathway activation in T-cells to create an intracellular factory of apoptosis-inducing signals
- Delivery of mRNA to activated T-cells mediated by targeting moieties on LNPs
